DEA Reduces Opioid Manufacturing for 2017
http://www.pharmacytimes.com/news/dea-reduces-opioid-manufacturing-for-2017
While the DEA claims that they are “NOT DOCTORS” … theirs – and other parts of the Federal government’s alphabetic soup of agencies … actions… have apparently caused a reduced prescribing of opiates… This suggests two things…. more and more chronic pain pts with a medical necessity of taking opiates… are getting FEWER prescriptions and could suggest why there are more people are ODing from purchasing opiates on “the street” to help them deal with their relentless chronic pain… or those suffering from the mental health disease of addictive personality disorder and – for whatever reason – have chose to try and deal with the monkeys on their backs and/or demons in their heads.. because our judicial system has declared that certain addictions is a CRIME and not a DISEASE… prohibiting them from seeking appropriate medical care from a licensed healthcare prescriber.
Under a Final Order being published in the Federal Register tomorrow, the DEA is reducing the amount of almost every Schedule II opiate and opioid medication by 25% or more next year. For instance, hydrocodone manufacturing in 2017 will be 66% of last year’s level.
The 2017 Aggregate Production Quota (APQ) established by the Final Order will reduce manufacturing of oxycodone, hydrocodone, fentanyl, hydromorphone, morphine, and other opioid medications. The APQ is the total amount of controlled substance necessary to meet the estimated medical, scientific, research, industrial, and export needs for the year and for the maintenance of reserve stocks.
Sales data obtained from IMS Health has shown a decreased demand for these opioid medications. Opioid demand is determined by the amount of prescriptions written by DEA-registered practitioners.
The manufacturing reductions come amid growing concerns about opioid abuse and increasing opioid-related deaths. The CDC issued guidelines earlier this year recommending reducing prescription medications for chronic pain in an effort to combat the misuse of opioids. However, much of the reduction for 2017 is attributed to the elimination of a 25% buffer that was added to the APQ annually in 2013 through 2016 to guard against drug shortages.
The DEA’s APQ system is intended to provide for the adequate and uninterrupted supply for legitimate medical need of Schedule I and II controlled substances, as well as limiting the amount available to prevent diversion. Annual APQs are established for more than 250 Schedule I and II controlled substances.
Once the APQ is set, the DEA allocates individual manufacturing and procurement quotas to companies that apply for it. The DEA can revise a company’s quota any time during the year due to increased sales or exports, new manufacturers entering the market, new product development, or product recalls.
Filed under: General Problems
How the f*** can they get away with this!? WTF are we suppose to do, its bad enough we are having our meds reduced to ineffective doses and many have had their meds abruptly stopped as it is, , this barbaric action is going to cause thousands and thousands of deaths at alarming rates. Who the hell has the power to stop this shit!?’
and they do this right along side trying to emergency schedule kratom? it’s difficult to see this is anything other than a plan to cause pain and death.
”They” gotta ,”prove” there willfull torture and genocide is working,,even if the have to lie to do it,,,Can’t u hear the dea now,,,”seeee,,we have reduce the manufacturing of,” drugs,” by 37 %,”’,,,telling our next adminstatration……..No matter,, we have committed torture and genocide in the process,,,,,it all about proving a lie,,,,as always,,,thus their employment need,,,,maryw
Wow I can see the shortage now especially, state that have had problems like Florida. Make sure you become a great customer at your local pharmacy.
So this will reduce opioid overdoses? This will push 1000s to the streets for heroin and ODs will skyrocket. Stupid move Mr. DEA man.